Header

Sub Navigation

  Close Menu

Opioid Settlement

The Office of Drug Prevention, Treatment, and Enforcement in partnership with the Indiana Family and Social Services Administration - Division of Mental Health and Addiction and the Indiana Department of Health is developing a framework for how the State of Indiana plans to use the state portion of funds from the national opioid settlement with distributors McKesson, Cardinal Health and AmerisourceBergen and manufacturer Janssen Pharmaceuticals, Inc. and its parent company Johnson & Johnson. House Enrolled Act 1193, passed by the Indiana General Assembly and signed by Governor Eric J. Holcomb in March 2022, creates a 50/50 state and local split and defines the intensity metrics on how much money each locality will receive.

The State is using the Johns Hopkins Bloomberg School of Public Health's five guiding principles to ensure dollars are used most effectively:

  1. Spend the money to save lives
  2. Use evidence to guide spending
  3. Invest in youth prevention
  4. Focus on racial equity
  5. Develop a fair and transparent process for deciding where to spend the funds.

Exhibit E of the national settlement document outlines the approved abatement uses.

Click here to view distribution totals for participating subdivisions.

Check back for updates on Indiana's funding plan.


Frequently Asked Questions

How much money should my community expect to receive?

The Indiana Office of the Attorney General calculates the amounts local units of governments are to receive from the settlement per the terms and conditions of the settlement and House Enrolled Act 1193.  The OAG will provide the amounts to the State Budget Agency, which then is responsible for determining and calculating any attorney fees that must be paid from a local unit of government allocation prior to distribution. Click here to view distribution totals for participating subdivisions.

How do I know if my community expects to receive funding?

Over 640 Indiana towns, cities, and counties have opted into the state’s settlement with distributors McKesson, Cardinal Health, and AmerisourceBergen and manufacturer Janssen Pharmaceuticals, Inc., and its parent company Johnson & Johnson. Click here to view distribution totals for participating subdivisions.

How will funds be distributed?

House Enrolled Act 1193, passed by the Indiana General Assembly and signed by Governor Eric J. Holcomb in March 2022, creates a 50/50 state and local split and defines the intensity metrics on how much money each locality will receive.

When should Indiana expect to receive funds?

It is anticipated that the 2022 payments will be transferred to the participating subdivisions in Fall 2022.

How are funds being spent?

For the portion of the settlement allocated to the state, the state plans to make opportunities available to local units of government to apply for matching funds for programs. These opportunities are scheduled to be released in Fall 2022.

The state’s spending plan must be approved by the State Budget Committee prior to implementation.

Who is the point of contact?

House Enrolled Act 1193 defines the responsibilities of involved state agencies.

What are the requirements for reporting how funds are spent?

At this time, information on reporting requirements has not been made available by the national settlement administrator.

How will Indiana be transparent?

The Office of the Governor has created a webpage at in.gov/recovery/settlement where updates will be regularly posted.


Additional Resources


Contact Us

To submit questions or ideas for how opioid settlement funds should be spent, contact us at drugpte@gov.in.gov.